BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21978192)

  • 1. Manual acupuncture for relieving pain associated with panretinal photocoagulation.
    Chiu HH; Wu PC
    J Altern Complement Med; 2011 Oct; 17(10):915-21. PubMed ID: 21978192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for relieving pain associated with panretinal photocoagulation: a prospective randomized trial.
    Wu WC; Hsu KH; Chen TL; Hwang YS; Lin KK; Li LM; Shih CP; Lai CC
    Eye (Lond); 2006 Jun; 20(6):712-9. PubMed ID: 16021194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panretinal photocoagulation versus intravitreal injection retreatment pain in high-risk proliferative diabetic retinopathy.
    Lucena CR; Ramos Filho JA; Messias AM; Silva JA; Almeida FP; Scott IU; Ribeiro JA; Jorge R
    Arq Bras Oftalmol; 2013; 76(1):18-20. PubMed ID: 23812521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral versus topical diclofenac for pain prevention during panretinal photocoagulation.
    Zakrzewski PA; O'Donnell HL; Lam WC
    Ophthalmology; 2009 Jun; 116(6):1168-74. PubMed ID: 19376588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy.
    Bandello F; Brancato R; Menchini U; Virgili G; Lanzetta P; Ferrari E; Incorvaia C
    Semin Ophthalmol; 2001 Mar; 16(1):12-8. PubMed ID: 15487693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    ; Gross JG; Glassman AR; Jampol LM; Inusah S; Aiello LP; Antoszyk AN; Baker CW; Berger BB; Bressler NM; Browning D; Elman MJ; Ferris FL; Friedman SM; Marcus DM; Melia M; Stockdale CR; Sun JK; Beck RW
    JAMA; 2015 Nov; 314(20):2137-2146. PubMed ID: 26565927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study.
    Muqit MM; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
    Arch Ophthalmol; 2010 May; 128(5):525-33. PubMed ID: 20457972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central retinal thickness following panretinal photocoagulation using a multispot semi-automated pattern-scanning laser to treat ischaemic diabetic retinopathy: Treatment in one session compared with four monthly sessions.
    Gabrielle PH; Massin P; Kodjikian L; Erginay A; Pallot C; Jonval L; Soudry A; Couturier A; Vardanian-Vartin C; Bron AM; Creuzot-Garcher C
    Acta Ophthalmol; 2019 Aug; 97(5):e680-e687. PubMed ID: 30561087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain responses of Pascal 20 ms multi-spot and 100 ms single-spot panretinal photocoagulation: Manchester Pascal Study, MAPASS report 2.
    Muqit MM; Marcellino GR; Gray JC; McLauchlan R; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
    Br J Ophthalmol; 2010 Nov; 94(11):1493-8. PubMed ID: 20558423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transnasal sphenopalatine ganglion block for pain relief during panretinal photocoagulation laser for diabetic retinopathy: a pre and post interventional study.
    Sanatkar M; Bazvand F
    Sci Rep; 2022 Jun; 12(1):10964. PubMed ID: 35768623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
    Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
    Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
    Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR;
    JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
    JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.
    Filho JA; Messias A; Almeida FP; Ribeiro JA; Costa RA; Scott IU; Jorge R
    Acta Ophthalmol; 2011 Nov; 89(7):e567-72. PubMed ID: 21726427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHOROIDAL THICKNESS CHANGES IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION WITH INTRAVITREAL BEVACIZUMAB.
    Roohipoor R; Sharifian E; Ghassemi F; Riazi-Esfahani M; Karkhaneh R; Fard MA; Zarei M; Modjtahedi BS; Moghimi S
    Retina; 2016 Oct; 36(10):1997-2005. PubMed ID: 27046456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Panretinal Photocoagulation Plus Intravitreal Bevacizumab Versus Panretinal Photocoagulation Alone for Proliferative Diabetic Retinopathy.
    Ali W; Abbasi KZ; Raza A
    J Coll Physicians Surg Pak; 2018 Dec; 28(12):923-927. PubMed ID: 30501828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of pain experience and time required for pre-planned navigated peripheral laser versus conventional multispot laser in the treatment of diabetic retinopathy.
    Amoroso F; Pedinielli A; Astroz P; Semoun O; Capuano V; Miere A; Souied EH
    Acta Diabetol; 2020 May; 57(5):535-541. PubMed ID: 31749047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Shiono T
    Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.
    Mason JO; Yunker JJ; Vail R; McGwin G
    Retina; 2008 Oct; 28(9):1319-24. PubMed ID: 18667958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Spot Yellow Laser Versus Conventional Green Laser on Panretinal Photocoagulation: Patient Pain Scores and Preferences.
    González-Saldivar G; Rojas-Juárez S; Espinosa-Soto I; Sánchez-Ramos J; Jaurieta-Hinojosa N; Ramírez-Estudillo A
    Ophthalmic Surg Lasers Imaging Retina; 2017 Nov; 48(11):902-905. PubMed ID: 29121359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.